Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-κB, activator protein-1, and apoptosis: Potential role of reactive oxygen intermediates and lipid peroxidation

Journal of Immunology

Volumn 164, Issue 12, 2000, Pages 6509-6519

  Manna, Sunil K ^a   Mukhopadhyay, Asok ^a   Aggarwal, Bharat B ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CERAMIDE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; OKADAIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE; PHYTOALEXIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC TRANSCRIPTION; HELA CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LIPID PEROXIDATION; PRIORITY JOURNAL; REPORTER GENE;

EID: 0034660659     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.12.6509     Document Type: Article

References (73)

1. Soleas, G. J., E. P. Diamandis, and D. M. Goldberg. 1997. Resveratrol: a molecule whose time has come? And gone? Clin. Biochem. 30:91.
2. Hain, R., B. Bieseler, H. Kindl, G. Schroder, and R. Stocker. 1990. Expression of a stilbene synthase gene in Nicotiana tabacum results in synthesis of the phytoalexin resveratrol. Plant Mol. Biol. 15:325.
3. Langcake, P., and R. J. Pryce. 1977. A new class of phytoalexins from grape-vines. Experientia 33:151.
4. Rimm, E. B. 1996. Alcohol consumption and coronary heart disease: good habits may be more important than just good wine. Am. J. Epidemiol. 143:1094.
5. Goldberg, D. M., S. B. Hahn, and J. G. Parkes. 1995. Beyond alcohol: beverage consumption and cardiovascular mortality. Clin. Chim. Acta 237:155.
6. Pace-Asciak, C. R., S. Hahn, E. P. Diamandis, G. Soleas, and D. M. Goldberg. 1995. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin. Chim. Acta 235:207.
7. Bertelli, A. A., L. Giovannini, D. Giannessi, M. Migliori, W. Bernini, M. Fregoni, and A. Bertelli. 1995. Antiplatelet activity of synthetic and natural resveratrol in red wine. Int. J. Tissue React. 17:1.
8. Frankel, E. N., A. L. Waterhouse, and J. E. Kinsella. 1993. Inhibition of human LDL oxidation by resveratrol. Lancet 341:1103.
9. Kerry, N. L., and M. Abbey. 1997. Red wine and fractionated phenolic compounds prepared from red wine inhibit low density lipoprotein oxidation in vitro. Atherosclerosis 135:93.
10. 2. Cancer Res. 59:2596.
11. Fontecave, M., M. Lepoivre, E. Elleingand, C. Gerez, and O. Guittet. 1998. Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett. 421: 277.
12. Sun, N. J., S. H. Woo, J. M. Cassady, and R. M. Snapka, 1998. DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia. J. Natl. Prod. 61:362.
13. Mgbonyebi, O. P., J. Russo, and I. H. Russo. 1998. Antiproliferative effect of synthetic resveratrol on human breast epithelial cells. Int. J. Oncol. 12:865.
14. Jang, M., L. Cai, G. O. Udeani, K. V. Slowing, C. F. Thomas, C. W. Beecher, H. H. Fong, N. R. Farnsworth, A. D. Kinghorn, R. G. Mehta, et al. 1997. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218.
15. Clement, M. V., J. L. Hirpara, S. H. Chawdhury, and S. Pervaiz. 1998. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92:996.
16. Hsieh, T. C., P. Burfeind, K. Laud, J. M. Backer, F. Traganos, Z. Darzynkiewicz, and J. M. Wu. 1999. Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials. Int. J. Oncol. 15:245.
17. Hsieh, T. C., and J. M. Wu. 1999. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Exp. Cell Res. 249:109.
18. Subbaramaiah, K., W. J. Chung, P. Michaluart, N. Telang, T. Tanabe, H. Inoue, M. Jang, J. M. Pezzuto, and A. J. Dannenberg. 1998. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem. 273:21875.
19. Jang, M., and J. M. Pezzuto. 1998. Effects of resveratrol on 12-O-tetradecanoyl-phorbol-13-acetate-induced oxidative events and gene expression in mouse skin. Cancer Lett. 134:81.
20. Ciolino, H. P., P. J. Daschner, and G. C. Yeh. 1998. Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor. Cancer Res. 58:5707.
21. Gehm, B. D., J. M. McAndrews, P. Y. Chien, and J. L. Jameson. 1997. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. USA 94:14138.
22. Baeuerle, P. A., and V. R. Baichwal. 1997. NF-κB as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv. Immunol. 65:111.
23. Suganuma, M., S. Okabe, M. W. Marino, A. Sakai, E. Sueoka, and H. Fujiki. 1999. Essential role of tumor necrosis factor α (TNF-α) in tumor promotion as revealed by TNF-α-deficient mice. Cancer Res. 59:4516.
24. Reuther, J. Y., G. W. Reuther, D. Cortez, A. M. Pendergast, and A. S. Baldwin Jr. 1998. A requirement for NF-κB activation in Bcr-Abl-medialed transformation. Genes Dev. 12:968.
25. Karin, M., Z. G. Liu, and E. Zandi, 1997. AP-1 function and regulation. Curr. Opin. Cell Biol. 9:240.
26. Smith, L. M., S. C. Wise, D. T. Hendricks, A. L. Sabichi, T. Bos, P. Reddy, P. H. Brown, and M. J. Birrer. 1999. c-Jun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype. Oncogene 18:6063.
27. Karin, M., and M. Delhase, 1998. JNK or IKK, AP-1 or NF-κB, which are the targets for MEK kinase 1 action? Proc. Natl. Acad. Sci. USA 95:9067.
28. Manna, S. K., H. J. Zhang, T. Yan, L. W. Oberley, and B. B. Aggarwal. 1998. Overexpression of Mn-superoxide dismutase suppresses TNF induced apoptosis and activation of nuclear transcription factor-κB and activated protein-1. J. Biol. Chem. 273:13245.
29. Manna, S. K., M. T. Kuo, and B. B. Aggarwal. 1999. Overexpression of γ-glutamylcysteine synthetase abolishes tumor necrosis factor-induced apoptosis and activation of nuclear transcriplion factor-κB and activator protein-1. Oncogene 18:4371.
30. Li, N., ard M. Karin. 1999. Is NF-κB the sensor of oxidative stress? FASEB J. 13:1137.
31. Kumar, A., and B. B. Aggarwal. 1999. Assay for redox sensitive kinases. Methods Enzymol. 300:339.
32. Zhou, G., and M. T. Kuo. 1997. NF-κB-mediated induction of mdrlb expression by insulin in rat hepatoma cells. J. Biol. Chem. 272:15174.
33. Chaturvedi, M., A. Kumar, B. G. Darnay, G. B. N. Chainy, S. Agarwal, and B. B. Aggarwal. 1997. Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-κB activation. J. Biol. Chem. 272:30129.
34. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with "mini-extracts," prepared from a small number of cells. Nucleic Acids Res. 17:6419.
35. Haridas, V., B. G. Darnay, K. Natarajan, R Heller, and B. B. Aggarwal. 1998. Overexpression of the p80 form of the TNF receptor induces apoptosis. NF-κB activation and c-Jun kinase activation: comparison with the endogenous receptor. J. Immunol. 160:3152.
36. Tewari, M., L. T. Quan, K. O' Rourke, S. Desnoyers, Z. Zeng, D. R. Beidler, G. G. Poirier, G. S. Salvesan, and V. M. Dixit. 1995. Yama/CPP32 β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81:801.
37. Cowley, S., H. Paterson, P. Kemp, and C. J. Marshall. 1994. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77:841.
38. Sambrook, J., E. E. Fritch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual, 2nd Ed. Cold Spring Harbor Laboratory, Cold Spring Harbor.
39. Manna, S. K., A. Mukhopadhyay, N. T. Van, and B. B. Aggarwal. 1999. Silymarin suppresses TNF-induced activation of nuclear transcription factor-κB, c-Jun N-terminal kinase and apoptosis. J. Immunol. 162:0000.
40. Chaturvedi, M. M., R. LaPushin, and B. B. Aggarwal. 1994. Tumor necrosis factor and lymphotoxin: qualitative and quantitative differences in the mediation of early and late cellular responses. J. Biol. Chem. 269:14575.
41. Mahon, T. M., and L. A. O'Neill. 1995. Studies into the effect of the tyrosine kinase inhibitor herbimycin A on NF-κB activation in T lymphocytes: evidence for covalent modification of the p50 subunit. J. Biol. Chem. 270:28557.
42. Finco, T. S., A. A. Beg, and A. S. Baldwin 1994. Inducible phosphorylation of 1κBα is not sufficient for its dissociation from NF-κB and is inhibited by protease inhibitors. Proc. Natl. Acad. Sci. USA 91:11884.
43. Natarajan, K., S. Singh, T. R. Burke Jr., D. Grunberger, and B. B. Aggarwal. 1996. Caffeic acid phenethyl ester (CAPE) is a potent and specific inhibitor of activation of nuclear transcription factor NF-κB. Proc. Natl. Acad. Sci. USA 93:9090
44. Bonizzi, G., J. Pietle, M. P. Merville, and V. Bours. 1997. Distinct signal transduction pathways mediate nuclear factor-κB induction by IL-1β in epithelial and lymphoid cells. J. Immunol. 159:5264.
45. Li, N., and M. Karin. 1998. Ionizing radiation and short wavelength UV activate NF-κB through two distinct mechanisms. Proc. Natl. Acad. Sci. USA 95:13012.
46. Imbert, V., R. A. Rupec, A: Livolsi, H. L. Pahl, E. B.-M. Traenckner, C. Mueller-Dieckmann, D. Farahifar, B. Rossi, P. Auberger, P. A. Baeuerle, and J.-F. Peyron. 1996. Tyrosine phosphorylation of 1κB-α activates NF-κB without protcolytic degradation of 1κB-β. Cell 86:787.
47. Egan, L. J., D. C. Mays, C. J. Huntoon, M. P. Bell, M. G. Pike, W. J. Sandborn, J. J. Lipsky, and D. J. McKean. 1999. Inhibition of interleukin-1-stimulated NF-κB RelA/p65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity. J. Biol. Chem. 274:26448.
48. Nasuhara, Y., I. M. Adcock, M. Catley, P. J. Barnes, and R. Newton. 1999. Differential 1κB kinase activation and 1κBα degradation by interleukin-1β and tumor necrosis factor-α in human U937 monocytic cells: evidence for additional regulatory steps in κB-dependent transcription. J. Biol. Chem. 274:19965.
49. Karin, M. 1998. Mitogen-activated protein kinase cascades as regulators of stress responses. Ann. NY Acad. Sci. 851:139.
50. Lee, F. S., J. Hagler, Z. J. Chen, and T. Maniatis. 1997. Activation of the IκBα kinase complex by MEKK1, a kinase of the JNK pathway. Cell 88:213.
51. Sluss, H. K., T. Barren, B. Derijard, and R. J. Davis. 1994. Signal transduction by tumor necrosis factor mediated by JNK protein kinases. Mol. Cell. Biol. 14: 8376.
52. Westwick, J. K., C. Weitzel, A. Minden, M. Karin, and D. A. Brenner. 1994. Tumor necrosis factor α stimulates AP-1 activity through prolonged activation of the c-Jun kinase. J. Biol. Chem. 269:26396.
53. Rath, P. C., and B. B. Aggarwal. 1999. TNF-induced signaling in apoptosis. J. Clin. Immunol. 19:350.
54. Lo, Y. Y. C., J. M. S. Wong, and T. F. Cruz. 1996. Reactive oxygen species mediate cytokine activation of c-Jun NH2-terminal kinases. J. Biol. Chem. 271: 15703.
55. 2 in NF-κB activation by either cytokine in both primary and transformed endothelial cells. J. Biol. Chem. 272:25941.
56. Singh, S., and B. B. Aggarwal. 1995. Activation of transcription factor NF-κB is suppressed by curcumin (Diferulolylmethane). J. Biol. Chem. 270:24995.
57. Jobin, C., C. A. Bradham, M. P. Russo, B. Juma, A. S. Narula, D. A. Brenner, and R. B. Sartor. 1999. Curcumin blocks cytokine-mediated NF-κB activation and proinflammatory gene expression by inhibiting inhibitory factor 1-κB kinase activity. J. Immunol. 163:3474.
58. Sakurai, H., C. Hiroaki, M. Hidetaka, S. Takahisa, and T. Wataru. 1999. IκB kinases phosphorylate NF-B p65 subunit on serine 536 in the transactivation domain. J. Biol. Chem. 274:30353.
59. Baichwal, V. R., and P. A. Baeuerle. 1997. Apoptosis: activate NF-κB or die? Curr. Biol. 7:R94.
60. Hwang, D., B. C. Jang, G. Yu, and M. Boudreau, 1997. Expression of mitogen-inducible cyclooxygenase induced by lipopolysaccharide: mediation through both mitogen-activated protein kinase and NF-κB signaling pathways in macrophages. Biochem. Pharmacol. 54:87.
61. Von Knethen, A., D. Callsen, and B. Brune. 1999. Superoxide attenuates macrophage apoptosis by NF-κB and AP-1 activation that promotes cyclooxygenase-2 expression. J. Immunol. 163:2858.
62. Taylor, B. S., M. E. de Vera, R. W. Ganster, Q. Wang, R. A. Shapiro, S. M. Morris Jr., T. R. Billiar, and D. A. Geller. 1998. Multiple NF-κB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J. Biol. Chem. 273:15148.
63. Sato, H., and M. Seiki. 1993. Regulatory mechanism of 92 RDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8:395.
64. Collins, T., M. A. Read, A. S. Neish, M. Z. Whitley, D. Thanos, and T. Maniatis. 1995. Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J. 9:899.
65. Iademarco, M. F., J. J. McQuillan, G. D. Rosen, and D. C. Dean. 1992. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J. Biol. Chem. 267:16323.
66. Hansen, S. K., C. Nerlov, U. Zabel, P. Verde, M. Johnsen, P. A. Baeuerle, and F. Blasi. 1992. A novel complex between the p65 subunit of NF-κB and c-Re1 binds to a DNA element involved in the phorbol ester induction of the human urokinase gene. EMBO J. 11:205.
67. Ginestra, A., S. Monea, G. Seghezzi, V. Dolo, H. Nagase, P. Mignatti, and M. L. Vittorelli. 1997. Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT1080 fibrosarcoma cells. J. Biol. Chem. 272:17216.
68. Hong, W. K., and M. B. Sporn. 1997. Recent advances in chemoprevention of cancer. Science 278:1073.
69. Chinery, R., R. D. Beauchamp, Y. Shyr, S. C. Kirkland, R. J. Coffey, and J. D. Morrow. 1998. Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells. Cancer Res. 58: 2323.
70. Wunsch, H. 1998. COX provides missing link in mechanism of aspirin in colon cancer. Lancet 351:1864.
71. Huang, C., J. Li, W.-Y. Ma, and Z. Dong. 1999. JNK activation is required for JB6 cell transformation induced by tumor necrosis factor-but not by 12-O-tetradecanoylphorbol-13-acetate. J. Biol. Chem. 274:29672.
72. Mitchell, S. H., W. Zhu, and C. Y. F. Young. 1999. Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells. Cancer Res. 59:5892.
73. Epperly, M., J. Bray, S. Kraeger, R. Zwacka, J. Engelhardt, E. Travis, and J. Greenberger. 1998. Prevention of late effects of irradiation lung damage by manganese superoxide dismutase gene therapy. Gene Ther. 5:196.